LumiraDx shares these and other findings from its second annual U.S. survey “Point of Care Diagnostics: A Clinician's View” WALTHAM, Mass., Dec. 08, 2022 (GLOBE NEWSWIRE) -- LumiraDx Limited (Nasdaq: ...

The global point-of-care testing (POCT) market is driven by rising patient demand, technological innovation, and supportive regulatory frameworks. Rapid diagnostics, enhanced chronic disease ...

Point-of-care-testing for suspected COVID-19 reduces time to results and may improve infection control, suggesting these tests might have clinical advantages over widely used laboratory PCR methods.

In clinical settings, point-of-care testing (POCT) provides rapid diagnostic information to help make clinical decisions as early as possible in the care and treatment of patients. Ensuring that such ...

DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "Global Point-of-Care Testing (POCT) Market - Trends and Forecast To 2024" report to their offering. The Global Point-of ...

WALTHAM, Mass., Dec. 08, 2022 (GLOBE NEWSWIRE) -- LumiraDx Limited (LMDX), a next-generation point of care diagnostics company, today announced findings from its second annual “Point of Care ...

Individuals are increasingly using home-based POCT devices such as ACCU-CHEK self-monitoring blood glucose device to conduct their own tests. The growing popularity of POC testing at home is therefore ...

EKF Diagnostics, the global in vitro diagnostics company, announces that a recent study has confirmed that its Quo-Test® A1c point-of-care testing (POCT) analyzer shows comparable performance to a lab ...

Point of Care Testing (POCT): defined as medical diagnostic testing at or near the point of care-that is, at the time and place of patient care.[1][2] This contrasts with the historical pattern in ...

Objectives The common cold is the main cause of medical time loss in elite sport. Rapid diagnosis has been a challenge that may be amenable to molecular point-of-care testing (POCT). Methods We ...